Outcome of Board Meeting.
ABBOTINDIA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Abbott India's Board approved unaudited financial results for Q3 FY26 (quarter ended December 31, 2025) and 9M FY26. Revenue from operations for Q3 stood at Rs. 1,724.04 Cr, up about 6.8% from Rs. 1,614.28 Cr in the same quarter last year. Net profit for the quarter was Rs. 375.96 Cr, up about 4.2% year-on-year from Rs. 360.78 Cr. Basic and diluted EPS for the quarter was Rs. 176.92 versus Rs. 169.78 a year ago. For the 9-month period, revenue grew to Rs. 5,219.54 Cr from Rs. 4,804.56 Cr, while profit rose to Rs. 1,157.09 Cr from Rs. 1,047.40 Cr. The company flagged an additional one-time expense of Rs. 35.10 Cr in employee costs due to the new Labour Codes. Separately, Deloitte Touche Tohmatsu India LLP was re-appointed as Internal Auditors for FY 2026-27, and the Limited Review Report from Walker Chandiok & Co LLP carried no qualifications.
Steady mid-single-digit revenue and profit growth for the quarter, with a sequential dip likely tied to the one-time labour code adjustment. Clean audit report and continuity in auditors should reassure investors; expect earnings to be the main price driver in the near term.